Related Experiment Video
Updated: Jul 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
The Substitute Groups in FDA-Approved Small Molecule Drugs in 2020 - 2024.
Zeqiao Gong1, Shuxiang Cheng1, Jianguo Qi1,2
1Henan Key Laboratory of Natural Medicine Innovation and Transformation, Henan University, Jinming Campus, Kaifeng 475004, Henan, China.
Medicinal chemists strategically use functional groups in drug discovery to enhance drug efficacy, safety, and pharmacokinetics. This review analyzes FDA-approved drugs to provide practical design principles for developing new therapeutics.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Pharmacology
Background:
- Substituent application is crucial for optimizing drug properties like efficacy, safety, and pharmacokinetics.
- Understanding functional group trends aids in designing effective small molecule therapeutics.
Purpose of the Study:
- To systematically catalog functional groups in FDA-approved small molecules from 2020-2024.
- To decipher the rationale behind the selection of specific substituents.
- To translate observed trends into practical design principles for medicinal chemists.
Main Methods:
- Systematic cataloging of functional groups in FDA-approved small molecules (2020-2024).
- Analysis of substituent usage and their impact on drug properties.
- Case study approach to illustrate design principles.
Main Results:
- Identified key functional groups and their prevalence in recent FDA-approved drugs.
- Elucidated the specific roles substituents play in addressing efficacy, safety, and pharmacokinetic challenges.
- Demonstrated how substituent choices influence therapeutic outcomes.
Conclusions:
- Strategic substituent selection is a vital component of modern drug design.
- This review provides actionable insights for medicinal chemists to improve therapeutic development.
- Trends in functional group application offer valuable guidance for future drug discovery efforts.
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Classes and Categories
Drug Regulation
Drug Discovery: Overview
Drug Nomenclature
